SPHK1 and hepatocellular carcinoma: As previously stated, there are studies that report contradictory findings, such as Uranbileg et al. [55] and Grammatikos et al. [56], who showed increased levels of ceramide in the serum of patients with HCC, while Cai et al. [57] reported a high expression of SphK in hepatocellular carcinoma tissue.